These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 28149783)
1. Efficacy and safety of ranibizumab for wet age-related macular degeneration in Chinese patients. Qi HJ; Li XX; Zhang JY; Zhao MW Int J Ophthalmol; 2017; 10(1):91-97. PubMed ID: 28149783 [TBL] [Abstract][Full Text] [Related]
2. [Optical Coherence Tomography Angiography-based Follow-up Observation of Wet Age-related Macular Degeneration after Intravitreal Anti-Ranibizumab Therapy]. Yuan MZ; Zhou HY; Chen YX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Jun; 41(3):359-366. PubMed ID: 31282330 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study. Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142 [TBL] [Abstract][Full Text] [Related]
4. Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study. Banister K; Cook JA; Scotland G; Azuara-Blanco A; Goulão B; Heimann H; Hernández R; Hogg R; Kennedy C; Sivaprasad S; Ramsay C; Chakravarthy U Health Technol Assess; 2022 Jan; 26(8):1-142. PubMed ID: 35119357 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal ranibizumab for exudative age-related macular degeneration with good baseline visual acuity. Saito M; Iida T; Kano M Retina; 2012 Jul; 32(7):1250-9. PubMed ID: 22446886 [TBL] [Abstract][Full Text] [Related]
18. Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment Witkin AJ; Rayess N; Garg SJ; Maguire JI; Storey P; Kaiser RS; Hsu J; Vander JF; Ho AC Semin Ophthalmol; 2017; 32(3):309-315. PubMed ID: 26337539 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study. Rouvas A; Petrou P; Vergados I; Pechtasides D; Liarakos V; Mitsopoulou M; Ladas I Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1609-16. PubMed ID: 19609550 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Time to Retreatment and Visual Function Between Ranibizumab and Aflibercept in Age-Related Macular Degeneration. Inoue M; Yamane S; Sato S; Sakamaki K; Arakawa A; Kadonosono K Am J Ophthalmol; 2016 Sep; 169():95-103. PubMed ID: 27320059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]